Article

MRI Better Than Expected for Spondyloarthritis Diagnosis

MRI has much greater diagnostic utility for patients with spondyloarthritis (SpA) than was documented previously. Low-grade acute and structural sacroiliac (SI) joint lesions may be present in patients with nonspecific back pain and healthy persons.

MRI has much greater diagnostic utility for patients with spondyloarthritis (SpA) than was documented previously. Low-grade acute and structural sacroiliac (SI) joint lesions may be present in patients with nonspecific back pain and healthy persons.

Weber and associates evaluated T1-weighted and short tau inversion recovery MRI scans of the SI joints obtained from patients 45 years or younger with ankylosing spondylitis (AS), preradiographic inflammatory back pain (IBP), or nonspecific back pain as well as healthy controls. Bone marrow edema, fat infiltration, erosion, and ankylosis were recorded according to standardized definitions. Sensitivity, specificity, and positive and negative likelihood ratios for the diagnosis of SpA were calculated on the basis of global assessment of the MRI scans.

Diagnostic utility was high for patients with AS and those with preradiographic IBP. For patients with IBP, detection of bone marrow edema alone enhanced sensitivity but reduced specificity. With detection of erosions, sensitivity was further enhanced; specificity did not change. A single lesion of the SI joint was seen in up to 27% of controls.

The authors noted that future studies focusing on standardized evaluation of SI joint lesions should address the contribution of structural SI joint damage to diagnosis in early SpA.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.